MARC details
000 -LEADER |
fixed length control field |
03544nam a22004215i 4500 |
001 - CONTROL NUMBER |
control field |
978-3-031-28536-3 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240729135323.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
230610s2023 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9783031285363 |
-- |
978-3-031-28536-3 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJG |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED027000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJG |
Source |
thema |
245 10 - TITLE STATEMENT |
Title |
Diabetes and COVID-19 |
Subtitle |
: Considerations and Clinical Management / |
250 ## - EDITION |
Edition statement |
1st ed. 2023. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2023. |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
XVIII, 219 p. 23 illus., 21 illus. in color. |
Other physical details |
online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Contemporary Endocrinology, |
International Standard Serial Number |
2523-3793 |
505 0# - CONTENTS |
Contents |
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention -- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance -- Risk of COVID-19 in Persons with Diabetes -- Pathophysiology of Lung Dysfunction in Diabetes -- Diabetic kidney disease and COVID-19 -- The Impact of COVID-19 on Diabetic Foot Ulcers -- Co-morbid obesity and its impact on diabetes and COVID-19 -- Overview of Inpatient Mgt of Diabetes and COVID 19 -- Management of critically ill persons with COVID-19 and diabetes -- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes -- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19) -- COVID-19 Vaccination in Persons with Diabetes -- COVID-19 Vaccination in Persons with Diabetes -- Long-haul COVID Symptoms in Person with Diabetes. |
520 ## - ABSTRACT |
Abstract |
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions. . |
650 #0 - SUBJECT HEADINGS |
Subject term |
Endocrinology. |
9 (RLIN) |
6049 |
650 14 - SUBJECT HEADINGS |
Subject term |
Endocrinology. |
9 (RLIN) |
6049 |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Myers, Alyson K. |
Relator term |
editor. |
710 2# - ADDED CORPORATE NAME |
Added corporate author |
SpringerLink (Online service) |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Contemporary Endocrinology, |
International Standard Serial Number |
2523-3793 |
856 ## - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
Link text |
Access resource |
245 ## - TITLE STATEMENT |
Medium |
[E-Book] |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
912 ## - |
-- |
ZDB-2-SME |
912 ## - |
-- |
ZDB-2-SXM |